Login
$ALPE
$0.00 +$0.00 (0.0%) Close

Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2025
As of Dec 31, 2025
Q3 FY2019
As of Sep 30, 2019
Q2 FY2019
As of Jun 30, 2019
Q1 FY2019
As of Mar 31, 2019
Q4 FY2018
As of Dec 31, 2018
Q3 FY2018
As of Sep 30, 2018
Q2 FY2018
As of Jun 30, 2018
Q1 FY2018
As of Mar 31, 2018
Q4 FY2017
As of Dec 31, 2017
Q3 FY2017
As of Sep 30, 2017
Q2 FY2017
As of Jun 30, 2017
Q1 FY2017
As of Mar 31, 2017
Q4 FY2016
As of Dec 31, 2016
Q2 FY2016
As of Jun 30, 2016
Q1 FY2016
As of Mar 31, 2016
Q3 FY2016
As of Sep 30, 2016
Q4 FY2015
As of Dec 31, 2015
Q4 FY2013
As of Dec 31, 2013
Q3 FY2013
As of Sep 30, 2013
Q2 FY2013
As of Jun 30, 2013
Cash
Grant receivables
Prepaid expenses
Total Current Assets
Total Assets
Current Liabilities
Accrued expenses
Accounts payable and accrued liabilities
Accounts payable - related party
Deferred grant income
Due to related parties
Total Current Liabilities
Total Liabilities
Mezzanine Equity
Total Mezzanine Equity
Common stock: $0.01 par value; 82,000,000 shares authorized; 73,644,797, 73,644,797 and 40,844,797 shares issued, respectively
Total common stock: $0.01 par value; 82,000,000 shares authorized; 73,644,797, 73,644,797 and 40,844,797 shares issued, respectively
Additional paid-in capital
Treasury stock at cost: 714,750 shares
Accumulated deficit
Stockholders' deficit attributed to alpha-En Corporation stockholders
Total Stockholders' Deficit
Total Liabilities, Mezzanine Equity and Stockholders' Deficit and Temporary Equity
Preferred stock value
Series A Preferred Stock
Series B Preferred Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support